Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Short term Debt (2023 - 2025)

Profound Medical (PROF) has 3 years of Short term Debt data on record, last reported at $4.5 million in Q3 2025.

  • For Q3 2025, Short term Debt changed N/A year-over-year to $4.5 million; the TTM value through Sep 2025 reached $4.5 million, changed N/A, while the annual FY2024 figure was $1.7 million, 17.44% down from the prior year.
  • Short term Debt reached $4.5 million in Q3 2025 per PROF's latest filing, up from $1.7 million in the prior quarter.
  • Across five years, Short term Debt topped out at $4.5 million in Q3 2025 and bottomed at $1.7 million in Q4 2024.
  • Average Short term Debt over 3 years is $2.8 million, with a median of $2.1 million recorded in 2023.
  • The widest YoY moves for Short term Debt: up 17.44% in 2024, down 17.44% in 2024.
  • A 3-year view of Short term Debt shows it stood at $2.1 million in 2023, then decreased by 17.44% to $1.7 million in 2024, then soared by 157.92% to $4.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $4.5 million in Q3 2025, $1.7 million in Q4 2024, and $2.1 million in Q4 2023.